Novavax Inc (NVAX)
4.19
+0.10
(+2.44%)
USD |
NASDAQ |
Apr 23, 16:00
4.12
-0.07
(-1.67%)
After-Hours: 20:00
Novavax Accounts Payable (Quarterly): 132.61M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 132.61M |
September 30, 2023 | 101.91M |
June 30, 2023 | 87.25M |
March 31, 2023 | 124.80M |
December 31, 2022 | 216.52M |
September 30, 2022 | 145.00M |
June 30, 2022 | 386.49M |
March 31, 2022 | 135.13M |
December 31, 2021 | 127.05M |
September 30, 2021 | 59.56M |
June 30, 2021 | 74.00M |
March 31, 2021 | 113.60M |
December 31, 2020 | 54.33M |
September 30, 2020 | 15.10M |
June 30, 2020 | 9.242M |
March 31, 2020 | 2.518M |
December 31, 2019 | 2.91M |
September 30, 2019 | 4.21M |
June 30, 2019 | 4.303M |
March 31, 2019 | 6.15M |
December 31, 2018 | 9.301M |
September 30, 2018 | 6.79M |
June 30, 2018 | 6.686M |
March 31, 2018 | 5.77M |
December 31, 2017 | 5.613M |
Date | Value |
---|---|
September 30, 2017 | 5.242M |
June 30, 2017 | 8.021M |
March 31, 2017 | 3.79M |
December 31, 2016 | 5.685M |
September 30, 2016 | 16.23M |
June 30, 2016 | 15.99M |
March 31, 2016 | 11.24M |
December 31, 2015 | 11.89M |
September 30, 2015 | 8.201M |
June 30, 2015 | 7.117M |
March 31, 2015 | 9.742M |
December 31, 2014 | 12.91M |
September 30, 2014 | 2.975M |
June 30, 2014 | 4.495M |
March 31, 2014 | 4.018M |
December 31, 2013 | 5.985M |
September 30, 2013 | 3.339M |
June 30, 2013 | 2.946M |
March 31, 2013 | 2.173M |
December 31, 2012 | 3.228M |
September 30, 2012 | 2.203M |
June 30, 2012 | 3.38M |
March 31, 2012 | 2.959M |
December 31, 2011 | 2.645M |
September 30, 2011 | 2.395M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.518M
Minimum
Mar 2020
386.49M
Maximum
Jun 2022
94.55M
Average
87.25M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
Pfizer Inc | 6.71B |
Moderna Inc | 520.00M |
Agilent Technologies Inc | 488.00M |
Lexicon Pharmaceuticals Inc | 14.39M |
Vaxart Inc | 1.584M |